IMMX
Immix Biopharma Inc
NASDAQ: IMMX · HEALTHCARE · BIOTECHNOLOGY
$8.93
+3.48% today
Updated 2026-04-30
Market cap
$505.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.89
Dividend yield
—
52W range
$2 – $12
Volume
0.7M
Immix Biopharma Inc (IMMX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-55.00%
ROA
-29.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-972811.00 | — | — | — |
| 2020 | $0.00 | $-1.15M | — | — | — |
| 2021 | $0.00 | $-24.38M | — | — | — |
| 2022 | $-89.52M | $-8.23M | 100.00% | 9.18% | 9.19% |
| 2023 | $0.00 | $-15.43M | — | — | — |
| 2024 | $0.00 | $-21.61M | — | — | — |
| 2025 | $0.00 | $-29.44M | — | — | — |